Shiow-Lin Pan

Hsu, K. C., HuangFu, W. C., Lin, T. E., Chao, M. W., Sung, T. Y., Chen, Y. Y., Pan, S. L., Lee, J. C., Tzou, S. C., Sun, C. M. & Yang, J. M., 十二月 1 2020, 於 : Scientific Reports. 10, 1, 10510.

研究成果: 雜誌貢獻 › 文章

開啟存取

Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors

Chang, F. L., Tsai, K. C., Lin, T. Y., Yang, T. W., Lo, Y. N., Chen, W. C., Chang, J. H., Lu, M. K., Chiou, C. T., Chen, P. H., Yen, Y., Pan, S. L. & Lee, Y. C., 一月 1 2020, 於 : BioMed Research International. 2020, 3415471.

研究成果: 雜誌貢獻 › 文章

開啟存取

4 引文斯高帕斯（Scopus）

Correction: Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells (Oncogenesis, (2017), 6, 7, (e359), 10.1038/oncsis.2017.61)

Huang, H. L., Wu, H. Y., Chu, P. C., Lai, I. L., Huang, P. H., Kulp, S. K., Pan, S. L., Teng, C. M. & Chen, C. S., 二月 1 2020, 於 : Oncogenesis. 9, 2, 27.

研究成果: 雜誌貢獻 › 評論/辯論

開啟存取

Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

Lin, C. F., Huang, H. L., Peng, C. Y., Lee, Y. C., Wang, H. P., Teng, C. M. & Pan, S. L., 一月 15 2020, 於 : Toxicology and Applied Pharmacology. 387, 114858.

研究成果: 雜誌貢獻 › 評論/辯論

開啟存取

Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

Liu, Y. M., HuangFu, W. C., Huang, H. L., Wu, W. C., Chen, Y. L., Yen, Y., Huang, H. L., Nien, C. Y., Lai, M. J., Pan, S. L. & Liou, J. P., 九月 15 2020, 於 : European Journal of Medicinal Chemistry. 202, 112633.

研究成果: 雜誌貢獻 › 評論/辯論

開啟存取

潘 秀玲

學歷

經歷

研究興趣

URL

獎項

潘秀玲